Heartsciences provides business update and reports second quarter fiscal 2025 financial results

Southlake, tx, dec. 16, 2024 (globe newswire) -- heartsciences inc. (nasdaq: hscs; hscsw) ("heartsciences" or the "company"), an artificial intelligence (ai)-powered medical technology company focused on transforming ecgs/ekgs to save lives through earlier detection of heart disease, today reported financial results for the second quarter fiscal 2025 ended october 31, 2024 and provided a business update.
HSCS Ratings Summary
HSCS Quant Ranking